ArticleEuropean journal of clinical pharmacology2014

Comparative safety profiles of intravitreal bevacizumab, ranibizumab and pegaptanib: the analysis of the WHO database of adverse drug reactions.

C Biagi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.